1. Home
  2. KORE vs LUNG Comparison

KORE vs LUNG Comparison

Compare KORE & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KORE Group Holdings Inc.

KORE

KORE Group Holdings Inc.

HOLD

Current Price

$4.60

Market Cap

77.5M

ML Signal

HOLD

Logo Pulmonx Corporation

LUNG

Pulmonx Corporation

HOLD

Current Price

$2.49

Market Cap

63.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KORE
LUNG
Founded
2003
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
77.5M
63.6M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
KORE
LUNG
Price
$4.60
$2.49
Analyst Decision
Hold
Buy
Analyst Count
1
7
Target Price
$5.00
$6.81
AVG Volume (30 Days)
57.0K
1.1M
Earning Date
11-12-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$285,408,000.00
$91,664,000.00
Revenue This Year
$1.26
$9.21
Revenue Next Year
$7.55
$5.03
P/E Ratio
N/A
N/A
Revenue Growth
0.06
15.59
52 Week Low
$1.10
$1.31
52 Week High
$4.88
$9.37

Technical Indicators

Market Signals
Indicator
KORE
LUNG
Relative Strength Index (RSI) 65.14 68.25
Support Level $4.25 $1.96
Resistance Level $4.61 $2.66
Average True Range (ATR) 0.24 0.19
MACD 0.01 0.08
Stochastic Oscillator 98.44 84.40

Price Performance

Historical Comparison
KORE
LUNG

About KORE KORE Group Holdings Inc.

Kore Group Holdings Inc provides Internet of Things (IoT) solutions and services. In addition to providing critical services to customers globally, it enables them to manage, deploy, and scale their IoT applications and use cases. It offers connectivity services, location-based services, device solutions, and managed and professional services for the development and support of IoT technology for the Machine-to-Machine market. It derives revenue from IoT Connectivity services, IoT Solutions services, SIMs (IoT Connectivity), and IoT devices (IoT Solutions). Geographically, the company generates the majority of its revenue from the United States and the rest from other countries.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

Share on Social Networks: